Clash over S4 to S3 downscheduling

Doctors's group disagrees with expansion of downscheduling S4 medicines with controls, citing patient safety concerns The Australian Medical Association (AMA) has again taken aim at pharmacy, this time over the TGA’s proposals to introduce new controls for medicines downscheduled to S3 status. In its submission to the consultation on the review of the Scheduling Policy